Most Recent Articles about AMPH
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call Transcript May 12, 2019 - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2019 Earnings Conference Call May 09, 2019 05:00 PM ET Company Participants Jason Shandell - President, General Counsel and Director William Peters - C
Amphastar Pharmaceuticals Inc (AMPH) Q1 2019 Earnings Call Transcript May 09, 2019 - AMPH earnings call for the period ending March 31, 2019.
MNK or AMPH: Which Is the Better Value Stock Right Now? Apr 26, 2019 - MNK vs. AMPH: Which Stock Is the Better Value Option?

Related Companies

Name Exchange Price Mkt Cap
AMRN Amarin Corporation plc NASDAQ $2.83 $838.67M
CTMX CytomX Therapeutics, Inc. NASDAQ $18.52 $832.73M
CARA Cara Therapeutics, Inc. NASDAQ $21.19 $832.56M
RVNC Revance Therapeutics, Inc. NASDAQ $23.5001 $868.04M
ASMB Assembly Biosciences, Inc. NASDAQ $34.41 $875.61M
Sector: Health Care > Industry: Major Pharmaceuticals